Cardiologists should consider prescribing GLP1 agents for CVD prevention in type 2 diabetes

Ildiko Lingvay
PHILADELPHIA — Although endocrinologists may routinely prescribe the newer classes of diabetes drugs approved for cardiovascular risk reduction, cardiologists and primary care providers should also consider using these agents for patients with type 2 diabetes and heart disease, according to a speaker here.
“Things have changed a lot in the last year and a half,” Ildiko Lingvay, MD, MPH, MSCS, associate professor of internal medicine at University of Texas Southwestern Medical Center, said during a presentation. “There has been some new history-setting here
Back to top button